82
52
Growth Score
-4 pts
Heat Score
-20 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
547715
Detectiome offers AI-enabled liquid biopsy solutions for early cancer detection, including the Revonco multi-cancer test.
- Arman Vali: Founder, CEO and Product Marketing ManagerPast Role: Yektanet, Co-Founder and Senior Product Marketing and Sales Strategist
About the Company
Detectiome develops AI-enabled liquid biopsy solutions for early cancer detection. Their flagship product, Revonco, is a multi-cancer early detection test optimized for Middle Eastern genetics. This blood test identifies multiple cancers at their earliest stages, improving treatment outcomes. Detectiome leverages AI and multiomics to revolutionize
cancer care and address late detection issues.
